XDG3.DE vs. 2B70.DE
Compare and contrast key facts about Xtrackers MSCI Global SDG 3 Good Health UCITS ETF 1C (XDG3.DE) and iShares Nasdaq US Biotechnology UCITS ETF (2B70.DE).
XDG3.DE and 2B70.DE are both exchange-traded funds (ETFs), meaning they are traded on stock exchanges and can be bought and sold throughout the day. XDG3.DE is a passively managed fund by Xtrackers that tracks the performance of the MSCI ACWI IMI SDG 3 Good Health and Well-being Select. It was launched on Jan 18, 2023. 2B70.DE is a passively managed fund by iShares that tracks the performance of the Nasdaq Biotechnology. It was launched on Oct 19, 2017. Both XDG3.DE and 2B70.DE are passive ETFs, meaning that they are not actively managed but aim to replicate the performance of the underlying index as closely as possible.
Performance
XDG3.DE vs. 2B70.DE - Performance Comparison
Loading graphics...
XDG3.DE vs. 2B70.DE - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | |
|---|---|---|---|---|
XDG3.DE Xtrackers MSCI Global SDG 3 Good Health UCITS ETF 1C | -3.31% | 1.47% | 9.58% | 2.52% |
2B70.DE iShares Nasdaq US Biotechnology UCITS ETF | 3.64% | 18.62% | 4.60% | 1.62% |
Returns By Period
In the year-to-date period, XDG3.DE achieves a -3.31% return, which is significantly lower than 2B70.DE's 3.64% return.
XDG3.DE
- 1D
- 1.21%
- 1M
- -4.31%
- YTD
- -3.31%
- 6M
- 2.47%
- 1Y
- -2.74%
- 3Y*
- 3.65%
- 5Y*
- —
- 10Y*
- —
2B70.DE
- 1D
- 1.60%
- 1M
- -0.58%
- YTD
- 3.64%
- 6M
- 18.58%
- 1Y
- 29.69%
- 3Y*
- 10.78%
- 5Y*
- 4.95%
- 10Y*
- —
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
XDG3.DE vs. 2B70.DE - Expense Ratio Comparison
Both XDG3.DE and 2B70.DE have an expense ratio of 0.35%.
Return for Risk
XDG3.DE vs. 2B70.DE — Risk / Return Rank
XDG3.DE
2B70.DE
XDG3.DE vs. 2B70.DE - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Xtrackers MSCI Global SDG 3 Good Health UCITS ETF 1C (XDG3.DE) and iShares Nasdaq US Biotechnology UCITS ETF (2B70.DE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| XDG3.DE | 2B70.DE | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | -0.16 | 1.31 | -1.48 |
Sortino ratioReturn per unit of downside risk | -0.10 | 1.83 | -1.93 |
Omega ratioGain probability vs. loss probability | 0.99 | 1.24 | -0.26 |
Calmar ratioReturn relative to maximum drawdown | -0.12 | 2.49 | -2.62 |
Martin ratioReturn relative to average drawdown | -0.31 | 10.78 | -11.09 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading graphics...
Sharpe Ratios by Period
| XDG3.DE | 2B70.DE | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | -0.16 | 1.31 | -1.48 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | — | 0.24 | — |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.24 | 0.36 | -0.12 |
Correlation
The correlation between XDG3.DE and 2B70.DE is 0.71, which is considered to be high. That indicates a strong positive relationship between their price movements. Having highly-correlated positions in a portfolio may signal a lack of diversification, potentially leading to increased risk during market downturns.
Dividends
XDG3.DE vs. 2B70.DE - Dividend Comparison
Neither XDG3.DE nor 2B70.DE has paid dividends to shareholders.
Drawdowns
XDG3.DE vs. 2B70.DE - Drawdown Comparison
The maximum XDG3.DE drawdown since its inception was -20.49%, smaller than the maximum 2B70.DE drawdown of -30.87%. Use the drawdown chart below to compare losses from any high point for XDG3.DE and 2B70.DE.
Loading graphics...
Drawdown Indicators
| XDG3.DE | 2B70.DE | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -20.49% | -30.87% | +10.38% |
Max Drawdown (1Y)Largest decline over 1 year | -13.54% | -15.56% | +2.02% |
Max Drawdown (5Y)Largest decline over 5 years | — | -30.87% | — |
Current DrawdownCurrent decline from peak | -9.38% | -1.07% | -8.31% |
Average DrawdownAverage peak-to-trough decline | -5.17% | -10.17% | +5.00% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 4.70% | 2.93% | +1.77% |
Volatility
XDG3.DE vs. 2B70.DE - Volatility Comparison
The current volatility for Xtrackers MSCI Global SDG 3 Good Health UCITS ETF 1C (XDG3.DE) is 4.27%, while iShares Nasdaq US Biotechnology UCITS ETF (2B70.DE) has a volatility of 6.80%. This indicates that XDG3.DE experiences smaller price fluctuations and is considered to be less risky than 2B70.DE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading graphics...
Volatility by Period
| XDG3.DE | 2B70.DE | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 4.27% | 6.80% | -2.53% |
Volatility (6M)Calculated over the trailing 6-month period | 10.22% | 14.03% | -3.81% |
Volatility (1Y)Calculated over the trailing 1-year period | 16.97% | 22.48% | -5.51% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 13.09% | 20.46% | -7.37% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 13.09% | 21.78% | -8.69% |